PFIZER
Back to Cashflow Statement
|
PFIZER Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹968 Cr | ₹660 Cr | ₹257 Cr | ₹356 Cr | ₹667 Cr |
What is the latest Cash Flow from Operating Activities ratio of PFIZER ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹968 Cr |
| Mar2025 | ₹660 Cr |
| Mar2024 | ₹257 Cr |
| Mar2023 | ₹356 Cr |
| Mar2022 | ₹667 Cr |
How is Cash Flow from Operating Activities of PFIZER Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹968 Cr | 46.66 | |
| Mar2025 | ₹660 Cr | 156.87 | |
| Mar2024 | ₹257 Cr | -27.79 | |
| Mar2023 | ₹356 Cr | -46.68 | |
| Mar2022 | ₹667 Cr | - | |
Compare Cash Flow from Operating Activities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹20,877.6 Cr | -3.7% | 1.5% | -14.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | -3.7% |
1.5% |
-14.4% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses